metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Cómo ven la especialidad las nuevas generaciones de microbiólogos
Journal Information
Vol. 28. Issue S3.
La microbiología clínica actual en España: buscando salidas para afrontar el futuro
Pages 45-50 (October 2010)
Share
Share
Download PDF
More article options
Vol. 28. Issue S3.
La microbiología clínica actual en España: buscando salidas para afrontar el futuro
Pages 45-50 (October 2010)
Full text access
Cómo ven la especialidad las nuevas generaciones de microbiólogos
How the new generations of microbiologists view the specialty
Visits
2578
Juan Carlos Rodríguez Díaza, Emilia Cercenado Mansillab,
Corresponding author
ecercenado@terra.es

Autor para correspondencia.
a Servicio de Microbiología, Hospital General Universitario, Elche, Alicante, España
b Servicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid, España
This item has received
Article information
Resumen

A pesar del importante papel de la microbiología clínica en nuestro sistema de salud, esta disciplina no está exenta de retos ni de dificultades. Para adaptarse a los nuevos tiempos es necesario: a) realizar cambios importantes en la tecnología y evolucionar hacia técnicas moleculares para ofrecer soluciones diagnósticas o terapéuticas rápidas; b) poner a punto métodos de diagnóstico de infecciones emergentes o importadas; c) asesorar en la interpretación de los resultados microbiológicos; d) favorecer la implantación de técnicas de diagnóstico de tipo point-of-care y asesorar sobre su utilización y desarrollo; e) instaurar sistemas de calidad en el laboratorio; f) apoyarse en la informática y en otras tecnologías para enviar información al clínico en tiempo real y para establecer una comunicación más eficiente con los médicos de atención primaria, con los laboratorios de salud pública y con las autoridades sanitarias; g) diseñar sistemas de trabajo en red con profesionales de otras disciplinas, y h) promover programas de formación continuada. Solamente si los laboratorios de microbiología clínica están bien preparados, serán capaces de adoptar las novedades tecnológicas, nuestra disciplina alcanzará una mayor importancia dentro del sistema sanitario y obtendrá un mayor protagonismo social y reconocimiento por parte de las autoridades sanitarias.

Palabras clave:
Microbiología clínica
Pruebas point-of-care
Gestión de laboratorios
Nuevas tecnologías
Diagnóstico molecular
Abstract

Despite their pivotal role in the Spanish healthcare system, clinical microbiology laboratories are experiencing difficult times and tough challenges. The following changes are required to adapt to the new situation: a) the use of molecular diagnostics to provide rapid diagnosis; b) the development of diagnostic capabilities to identify emerging or imported infectious diseases; c) the ability to advise on the interpretation of microbiological results; d) encouragement of the implantation of point-of-care testing and assessment of its performance and development; e) the implantation of quality control systems in the laboratory; f) the implementation of laboratory information systems to support real-time communication between hospital and community clinicians, public health laboratories and managers; g) the design of networking systems with professionals from other disciplines, and h) the promotion of training and teaching programs. Only if they are well prepared will clinical microbiology laboratories be able to implant the new technologies, be recognized as a cornerstone of the healthcare system, and achieve better recognition by society at large, hospital administrators and healthcare authorities.

Keywords:
Clinical microbiology
Point of care testing
Laboratory management
New technologies
Molecular diagnostic
Full text is only aviable in PDF
Bibliografía
[1.]
E.J. Perea.
La microbiología clínica en el siglo XXI. Un nuevo escenario.
Enferm Infecc Microbiol Clin, 21 (2003), pp. 2-6
[2.]
A. Robinson, M. Marcon, J.E. Mortensen, I.S. McCarter, M. LaRocco, L.R. Paterson, et al.
Controversies affecting the future practice of clinical microbiology.
J Clin Microbiol, 37 (1999), pp. 883-889
[3.]
C. Fraser, C.A. Donnelly, S. Cauchemez, W.P. Hanage, M.D. Van Kerkhove, T.D. Hollingsworth, et al.
Pandemic potential of a strain of influenza A (H1N1): early findings.
Science, 324 (2009), pp. 1557-1561
[4.]
M. Washington, M. Brown, T. Palys, S. Tyner, R. Bowden.
Clinical microbiology during the Vietnam War.
Mil Med, 174 (2009), pp. 1209-1214
[5.]
J.H. Beigel.
Toward better clinical data in emerging infectious diseases.
Clin Infect Dis, 48 (2009), pp. 1647-1648
[6.]
O. Assadian, M. Diab-Elschahawi, A. Makristathis, A. Blacky, W. Koller, K.P. Adlassnig.
Data correction pre-processing for electronically stored blood culture results: implications on microbial spectrum and empirical antibiotic therapy.
BMC Med Inform Decision Making, 9 (2009), pp. 27
[7.]
P.P. Bourbeau, B.L. Swartz.
First evaluation of the WASP, a new automated microbiology plating instrument.
J Clin Microbiol, 47 (2009), pp. 1101-1106
[8.]
J. Weile, C. Knabbe.
Current applications and future trends of molecular diagnostics in clinical bacteriology.
Anal Bioanal Chem, 394 (2009), pp. 731-742
[9.]
V. Sintchenko, B. Gallego.
Laboratory-guided detection of disease outbreaks: three generations of surveillance systems.
Arch Pathol Lab Med, 133 (2009), pp. 916-925
[10.]
L.R. Peterson, J.D. Hamilton, E. Jo Baron, L.S. Tompkins, J.M. Miller, C.M. Wilfert, et al.
Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care.
Med Microbiol, 32 (2001), pp. 605-610
[11.]
B.T. Kalish, C.A. Gaydos, Y.H. Hsieh, B.E. Christensen, K.C. Carroll, A. Cannons, et al.
National survey of Laboratory Response network sentinel laboratory preparedness.
Disaster Med Public Health Prep, 3 (2009), pp. S17-S23
[12.]
W.F. Klietmann, K.L. Ruoff.
Bioterrorism: implications for the clinical microbiologist.
Clin Microbiol Rev, 14 (2001), pp. 364-381
[13.]
E.M. Marlowe, D.M. Wolk.
GeneXpert testing: applications for clinical microbiology. Part I.
Clin Microbiol Newsletter, 30 (2008), pp. 175-179
[14.]
J.J. Picazo.
¿Externalización de la microbiología clínica?.
Enf Infecc Microbiol Clin, 18 (2000), pp. 1
[15.]
J. Barenfanger, C. Drake, G. Kacich.
Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.
J Clin Microbiol, 37 (1999), pp. 1415-1418
[16.]
K.L. Muldrew.
Molecular diagnostics of infectious diseases.
Curr Opin Pediatr, 21 (2009), pp. 102-111
[17.]
M. Kami, T. Fukui, S. Ogawa, Y. Kazuyama, U. Machida, Y. Tanaka, et al.
Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis.
Clin Infect Dis, 33 (2001), pp. 1504-1512
[18.]
B. Carman.
Molecular techniques should now replace cell culture in diagnostic virology laboratories.
Rev Med Virol, 11 (2001), pp. 347-349
[19.]
M.B. Miller, Y.W. Tang.
Basic concepts of microarrays and potential applications in clinical microbiology.
Clin Microbiol Rev, 22 (2009), pp. 611-633
[20.]
K. Xiao-Ping, L. Yong-Qiang, S. Qing-Ge, L. Hong, Z. Qing-Yu, Y. Yin-Hui.
Development of a consensus microarray method for identification of some highly pathogenic viruses.
J Med Virol, 81 (2009), pp. 1945-1950
[21.]
L.E. Alksne, S.J. Projan.
Bacterial virulence as a target for antimicrobial chemotherapy.
Curr Opin Biotechnol, 11 (2000), pp. 625-636
[22.]
H.J. Kolmos.
Interaction between the microbiology laboratory and clinician: what the microbiologist can provide.
J Hosp Infect, 43 (1999), pp. S285-S291
[23.]
I.D. Wilson.
Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring.
Proc Natl Acad Sci USA, 106 (2009), pp. 14187-14188
[24.]
A. Telenti, V. Aubert, F. Spertini.
Individualizing HIV treatment -pharmacogenetics and immunogenetics.
[25.]
H. Hitoto, M. Eveillard, C. Lemarié, J. Cottin, M.L. Joly-Guillou.
Assessing the usefulness of a permanently opened clinical microbiology laboratory.
Med Mal Infect, 40 (2010), pp. 219-225
[26.]
M.A. Pfaller, L.A. Herwaldt.
The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology.
Clin Infect Dis, 25 (1997), pp. 858-870
[27.]
F. Baquero, R. Cantón, G. Cornaglia.
Public-health microbiology, a challenge for Europe.
Clin Microbiol Infect, 16 (2010), pp. 123-125
[28.]
I. García-Merino, N. De las Cuevas, J.L. Jiménez, J. Gallego, C. Gómez, C. Prieto, et al.
The Spanish HIV BioBank: a model of cooperative HIV research.
Retrovirology, 6 (2009), pp. 27
[29.]
K.M. Kuper, D.M. Boles, J.F. Mohr, A. Wanger.
Antimicrobial susceptibility testing: a primer for clinicians.
Pharmacotherapy, 29 (2009), pp. 1326-1343
[30.]
W. Suhanic, I. Crandall, P. Pennefather.
An informatics model for guiding assembly of telemicrobiology workstations for malaria collaborative diagnostics using commodity products and open-source software.
[31.]
M.D. Rojo, J.M. Aguiar, E. Cercenado, F. De Ory, M. De la Rosa.
Recomendaciones para la implantación de la normativa de calidad ISO 15189 en el laboratorio de microbiología clínica: bacteriología y serología.
Enferm Infecc Microbiol Clin, (2009),
[32.]
V. Ausina.
El microbiólogo clínico del futuro.
Enferm Infecc Microbiol Clin, 21 (2003), pp. 7-8
[33.]
J. Barenfanger.
Clinical microbiology laboratories can directly benefit patients.
ASM News, 67 (2001), pp. 71-77
Copyright © 2010. Elsevier España S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos